Detalles de la búsqueda
1.
A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results.
J Am Acad Dermatol
; 86(1): 122-130, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555481
2.
Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.
J Infect Dis
; 212(6): 959-67, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25748323
3.
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis.
RMD Open
; 9(2)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321668
4.
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
Am J Clin Dermatol
; 24(5): 821-835, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341961
5.
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study.
Paediatr Drugs
; 24(4): 377-387, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698000
6.
Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage.
Nat Microbiol
; 2: 16268, 2017 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28112722
Resultados
1 -
6
de 6
1
Próxima >
>>